Press "Enter" to skip to content

New patent for Sage Therap drug ZULRESSO

1
Copyright © DrugPatentWatch. Originally published at New patent for Sage Therap drug ZULRESSO

Annual Drug Patent Expirations for ZULRESSO
Annual Drug Patent Expirations for ZULRESSO

Zulresso is a drug marketed by Sage Therap and is included in one NDA. There are seven patents protecting this drug.

Drug patent litigation for ZULRESSO.

This drug has sixty-four patent family members in twenty-five countries.

The generic ingredient in ZULRESSO is brexanolone. Additional details are available on the brexanolone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Sage Therap drug ZULRESSO

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions